The Director of the Office of Professional and Occupational Regulation may establish by rule fees for purposes authorized under this chapter in amounts that are reasonable and necessary for their respective purposes in accordance with this section. Rules adopted pursuant to this section are routine technical rules as defined in Title 5, chapter 375, subchapter 2?A. [PL 2019, c. 536, §3 (NEW).]
1. General fees. Except as provided in subsection 2, the fee for any one purpose may not exceed $325.

[PL 2019, c. 536, §3 (NEW).]

Terms Used In Maine Revised Statutes Title 32 Sec. 13724

  • Drug: means :
A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Manufacturer: means a person engaged in the manufacture of prescription drugs. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Opioid medication: means a controlled substance containing an opioid included in schedule II of 21 United States Code § 812 or Title 21 of the Code of Federal Regulations, Part 1308. See Maine Revised Statutes Title 32 Sec. 13702-A
  • United States: includes territories and the District of Columbia. See Maine Revised Statutes Title 1 Sec. 72
    • 2. Manufacturer of an opioid medication fee. The fee for a manufacturer of an opioid medication is $55,000. This subsection does not apply to a manufacturer of an opioid medication if all of that manufacturer’s opioid medications are approved by the United States Food and Drug Administration for use only in veterinary medicine.

    [PL 2019, c. 536, §3 (NEW).]

    SECTION HISTORY

    PL 2005, c. 262, §B3 (NEW). PL 2007, c. 402, Pt. DD, §11 (AMD). PL 2011, c. 286, Pt. B, §5 (REV). PL 2019, c. 536, §3 (RPR).
      Previous section
    Next section  
     Subchapter 2 Contents